Petra Langerbeins

Also affiliated with Düsseldorf University Hospital, Integrated Oncology (United States), University Hospital Cologne, Heinrich Heine University Düsseldorf

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Reassessing the chronic lymphocytic leukemia International Prognostic Index in the era of targeted therapies”.

Reassessing the chronic lymphocytic leukemia International Prognostic Index in the era of targeted therapies

Blood(2024)10.1182/blood.2023022564

N/A

0.505DataRank · unranked

28 citations

Adam Giza, Sandra Robrecht, Paula Cramer, Julia von Tresckow, Othman Al-Sawaf +19 more

State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee

Blood Cancer Journal(2025)10.1038/s41408-025-01341-6

N/A

0DataRank · unranked

3 citations

Inhye E. Ahn, Aswin Sekar, Andy C. Rawstron, Júlia Almeida, José Ignacio Martin-Subero +18 more